Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

This study has been completed.
Sponsor:
Information provided by:
Canadian Cancer Trials Group
ClinicalTrials.gov Identifier:
NCT00107250
First received: April 5, 2005
Last updated: November 25, 2016
Last verified: January 2011